CorneaCare, Inc.

D2C dry eye solution steamlining diagnosis, treatment, compliance and education

https://wefunder.com/corneacare

Total raised on Wefunder: 65000

Total investors: 7

Quick facts

  • Dry eye disease afflicts 30m+ US adults; aging population, increased screen time, contact lens use
  • With 1.0% market capture (300,000 patients), CorneaCare could generate $126M of revenue per annum (not guaranteed)
  • Our eCommerce portal provides convenient and effective treatment packages delivered monthly.
  • Our digital therapeutic app promotes treatment compliance, monitoring, and collaborative care.
  • Our revenue is generated from a monthly subscription plan.

Team profiles

Featured investor profiles

CorneaCare, Inc.

D2C dry eye solution steamlining diagnosis, treatment, compliance and education

INVESTMENT TERMS
Future Equity
$5M valuation cap

What Investors Say

LEAD INVESTOR
Invested $2,500 this round
CorneaCare, Inc. is a great investment because it capitalizes on the increasing market share of the telehealth sector in order to treat extremely common eye conditions. Dry eye disease is an extremely common medical problem that plagues millions of individuals. It often follows a refractory course due to poor compliance. The combination of technology and medicine has great potential to ensure patient compliance and improve patient outcomes.
What People Say